Loading
NYSEHealthcareMedical - Devices
Latest quote
$68.85
+$2.16 · +3.24%
Inspire Medical Systems, Inc. operates as a medical technology enterprise, concentrating on the development and commercialization of advanced, minimally intrusive therapies for patients diagnosed with obstructive sleep apnea (OSA) across both domestic U.S. and international markets. A cornerstone of its product portfolio is the Inspire system, an innovative neurostimulation solution that offers a safe and proven effective treatment for individuals experiencing moderate to severe forms of OSA. Additionally, the company is pioneering a novel, closed-loop technology designed to continuously track a patient's breathing patterns and administer mild stimulation to the hypoglossal nerve, thereby maintaining an open airway. Founded in 2007, Inspire Medical Systems maintains its corporate headquarters in Golden Valley, Minnesota.
Regular session
$68.85
+$2.16 · +3.24%
Regular session · ET · Market data may be delayed.
Inspire Medical Systems, Inc. operates as a medical technology enterprise, concentrating on the development and commercialization of advanced, minimally intrusive therapies for patients diagnosed with obstructive sleep apnea (OSA) across both domestic U.S. and international markets. A cornerstone of its product portfolio is the Inspire system, an innovative neurostimulation solution that offers a safe and proven effective treatment for individuals experiencing moderate to severe forms of OSA. Additionally, the company is pioneering a novel, closed-loop technology designed to continuously track a patient's breathing patterns and administer mild stimulation to the hypoglossal nerve, thereby maintaining an open airway. Founded in 2007, Inspire Medical Systems maintains its corporate headquarters in Golden Valley, Minnesota.
Day range
Current $68.85
52-week range
Current $68.85
Regular session · ET · Market data may be delayed.
GoAI Score
Buy
Valuation
97
Deep Value
Sentiment
69
Bullish
Risk
51
Elevated Risk
Momentum
41
Neutral
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Inspire Medical Systems, Inc. operates as a medical technology enterprise, concentrating on the development and commercialization of advanced, minimally intrusive therapies for patients diagnosed with obstructive sleep apnea (OSA) across both domestic U.S. and international markets. A cornerstone of its product portfolio is the Inspire system, an innovative neurostimulation solution that offers a safe and proven effective treatment for individuals experiencing moderate to severe forms of OSA. Additionally, the company is pioneering a novel, closed-loop technology designed to continuously track a patient's breathing patterns and administer mild stimulation to the hypoglossal nerve, thereby maintaining an open airway. Founded in 2007, Inspire Medical Systems maintains its corporate headquarters in Golden Valley, Minnesota.
Day range
Current $68.85
52-week range
Current $68.85
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 911.98M USD | 802.8M USD | 624.8M USD | 407.86M USD | 233.39M USD |
| Cost of goods sold | 133.23M USD | 122.99M USD | 96.58M USD | 66.12M USD | 33.28M USD |
| Gross profit | 778.76M USD | 679.82M USD | 528.22M USD | 341.74M USD | 200.12M USD |
| Research and development | 103.17M USD | 114.13M USD | 116.54M USD | 68.65M USD | 37.35M USD |
| Selling, general, and administrative | 624.64M USD | 529.61M USD | 451.96M USD | 320.69M USD | 202.62M USD |
| Operating expenses | 727.8M USD | 643.74M USD | 568.49M USD | 389.33M USD | 239.97M USD |
| Interest income | 17.54M USD | 23.25M USD | 20.56M USD | 5.05M USD | 125K USD |
| Interest expense | 137K USD | 22K USD | — | 1.68M USD | 2.13M USD |
| Depreciation and amortization | 13.96M USD | 6.55M USD | 2.85M USD | 1.86M USD | 1.22M USD |
| Operating income | 50.95M USD | 36.08M USD | −40.27M USD | −47.59M USD | −39.85M USD |
| Net income | 145.42M USD | 53.51M USD | −21.15M USD | −44.88M USD | −42.04M USD |
Company facts updated Oct 9, 2026.
Reported history and fiscal-year consensus
Reported history and fiscal-year consensus
Third-party consensus; not a GoAI recommendation.
Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI57.58M0.00%2.3T USD0.03%$381.72+0.57%
iShares Russell 2000 ETFIWM50.87M0.06%77.7B USD0.19%$278.8+0.44%
Vanguard Morningstar Small-Cap ETFVB41.72M0.02%185.3B USD0.03%$289.25+0.56%
Vanguard Morningstar Small-Cap Growth ETFVBK23.91M0.05%44.7B USD0.05%$343.94+0.98%
Vanguard Extended Market ETFVXF19.24M0.02%95.4B USD0.05%$234.63+0.64%
State Street SPDR Portfolio S&P 600 Small Cap ETFSPSM17.64M0.11%15.8B USD0.03%$53.425+0.12%
iShares Russell 2000 Growth ETFIWO15.49M0.11%14.04B USD0.24%$356.54+0.87%
Principal U.S. Small-Cap Multi-Factor ETFPSC12.26M0.45%2.6B USD0.38%$67.68+0.58%Vanguard Morningstar Total Stock Market ETFVTIiShares Russell 2000 ETFIWMVanguard Morningstar Small-Cap ETFVBVanguard Morningstar Small-Cap Growth ETFVBKVanguard Extended Market ETFVXFState Street SPDR Portfolio S&P 600 Small Cap ETFSPSMiShares Russell 2000 Growth ETFIWOPrincipal U.S. Small-Cap Multi-Factor ETFPSCAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
